Acta Chir Belg 2022 Feb 2:1-8. Epub 2022 Feb 2.
Department of Pathology, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, Targu Mures Romania.
The continuous-flow left ventricular assist device (CF-LVAD) is used to save the lives of patients in the final stage of congestive heart failure, replacing the pump function of the left ventricle. Although quality of life increases significantly, CF-LVAD-related complications might prove fatal, as in the case presented in this paper. A 20-year-old female, during her second pregnancy, presented with signs of heart failure. Read More